摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-Chloro-6-isopropylamino-2-methylsulfanyl-pyrimidine-5-carbaldehyde | 444605-21-4

中文名称
——
中文别名
——
英文名称
4-Chloro-6-isopropylamino-2-methylsulfanyl-pyrimidine-5-carbaldehyde
英文别名
4-chloro-6-isopropylamino-2-methylsulfanylpyrimidine-5-carbaldehyde;4-chloro-2-methylsulfanyl-6-(propan-2-ylamino)pyrimidine-5-carbaldehyde
4-Chloro-6-isopropylamino-2-methylsulfanyl-pyrimidine-5-carbaldehyde化学式
CAS
444605-21-4
化学式
C9H12ClN3OS
mdl
——
分子量
245.733
InChiKey
CDYKJLOLNQBHAZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    404.2±45.0 °C(Predicted)
  • 密度:
    1.30±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    15
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    80.2
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    A convenient synthesis of trisubstituted pyrido[2,3-d]pyrimidin-7-ones
    摘要:
    A novel, highly efficient and scalable route for the synthesis of trisubstituted pyrido[2,3-d]pyrimidin-7-ones was developed. The target compounds were synthesized in five steps from readily available reagents in about 40% overall yield. (C) 2003 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4039(03)00974-2
  • 作为产物:
    描述:
    异丙胺2-(甲硫基)-4,6-二氯-5-嘧啶甲醛4-Chloro-6-isopropylamino-2-methylsulfanyl-pyrimidine-5-carbaldehyde 作用下, 以to give the title compound 4-chloro-6-isopropylamino-2-methylsulfanyl-pyrimidine-5-carbaldehyde的产率得到4-Chloro-6-isopropylamino-2-methylsulfanyl-pyrimidine-5-carbaldehyde
    参考文献:
    名称:
    Novel compounds
    摘要:
    小说替代了2,4,8-三取代-8H-吡啶[2,3-d]嘧啶-7-酮化合物和组合物,用于治疗作为CSBP/p38激酶抑制剂。
    公开号:
    US20040209901A1
  • 作为试剂:
    描述:
    异丙胺2-(甲硫基)-4,6-二氯-5-嘧啶甲醛4-Chloro-6-isopropylamino-2-methylsulfanyl-pyrimidine-5-carbaldehyde 作用下, 以to give the title compound 4-chloro-6-isopropylamino-2-methylsulfanyl-pyrimidine-5-carbaldehyde的产率得到4-Chloro-6-isopropylamino-2-methylsulfanyl-pyrimidine-5-carbaldehyde
    参考文献:
    名称:
    2,4,8-TRISUBSTITUTED-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE COMPOUNDS AND COMPOSITIONS FOR USE IN THERAPY
    摘要:
    小说替代了2,4,8-三取代-8H-吡啶[2,3-d]嘧啶-7-酮化合物和组合物,用于作为CSBP/p38激酶抑制剂的治疗用途。
    公开号:
    US20110046109A1
点击查看最新优质反应信息

文献信息

  • Novel Compounds
    申请人:Adams L. Jerry
    公开号:US20050203109A1
    公开(公告)日:2005-09-15
    Novel substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
    小说替代2,4,8-三取代-8H-吡啶[2,3-d]嘧啶-7-酮化合物和组合物,用于作为CSBP / p38激酶抑制剂的治疗用途。
  • NOVEL COMPOUNDS
    申请人:Adams L. Jerry
    公开号:US20080032969A1
    公开(公告)日:2008-02-07
    Novel substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
    小说替代物2,4,8-三取代-8H-吡啶[2,3-d]嘧啶-7-酮化合物以及用于治疗的组合物作为CSBP/p38激酶抑制剂。
  • 4-amino substituted-6-aryl/heteroaryl substituted-2-methylsulfanyl-pyrimidine-5-carbaldehyde intermediates
    申请人:SmithKline Beecham Corporation
    公开号:US07314934B2
    公开(公告)日:2008-01-01
    Novel substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
    小说替代物2,4,8-三取代-8H-吡啶[2,3-d]嘧啶-7-酮化合物和组合物可用于治疗CSBP/p38激酶抑制剂。
  • 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds
    申请人:SmithKline Beecham Corporation
    公开号:US07314881B2
    公开(公告)日:2008-01-01
    Novel substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
    小说替代2,4,8-三取代-8H-吡啶[2,3-d]嘧啶-7-酮化合物和组合物作为CSBP/p38激酶抑制剂用于治疗。
  • 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy
    申请人:GlaxoSmithKline LLC
    公开号:US08058282B2
    公开(公告)日:2011-11-15
    Novel substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
    小说替代了2,4,8-三取代-8H-吡啶[2,3-d]嘧啶-7-酮化合物和组合物,用于作为CSBP/p38激酶抑制剂的治疗用途。
查看更多